Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats

Megalin has been proposed as an endocytic receptor for aminoglycosides as well as estrogen and androgen. We aimed to investigate the otoprotective effects of antiandrogens (flutamide, FM) on kanamycin (KM)-induced hearing loss in rats. Rats were divided into four groups. The KM group was administere...

Full description

Bibliographic Details
Main Authors: Kyung-Ju Chun, Chang-Ho Lee, Kyung-Woon Kim, So-Min Lee, So-Young Kim
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/10/5307
_version_ 1797533605288738816
author Kyung-Ju Chun
Chang-Ho Lee
Kyung-Woon Kim
So-Min Lee
So-Young Kim
author_facet Kyung-Ju Chun
Chang-Ho Lee
Kyung-Woon Kim
So-Min Lee
So-Young Kim
author_sort Kyung-Ju Chun
collection DOAJ
description Megalin has been proposed as an endocytic receptor for aminoglycosides as well as estrogen and androgen. We aimed to investigate the otoprotective effects of antiandrogens (flutamide, FM) on kanamycin (KM)-induced hearing loss in rats. Rats were divided into four groups. The KM group was administered KM (20 mg/kg/day) for 5 days, while the FM group received FM (15 mg/kg/day) for 10 days. In the KM + FM group, KM and FM (15 mg/kg/day) were simultaneously injected for 5 days and then FM was injected for 5 days. Auditory brainstem responses were measured. Western blotting and/or quantitative reverse transcriptase-polymerase chain reaction were performed for megalin, cytochrome P450 1A1 (Cyp1a1), Cyp1b1, metallothionein 1A (MT1A), MT2A, tumor necrosis factor (TNF)-α, caspase 3, and cleaved caspase 3. The FM + KM group showed attenuated auditory thresholds when compared with the KM group at 4, 8, 16, and 32 kHz (all <i>p</i> < 0.05). The KM + FM group showed lower megalin and Cyp1b1 levels than the KM group (all <i>p</i> < 0.05). The KM + FM group revealed lower MT1A, TNFα, and caspase 3 protein levels, compared with those in the KM group (all <i>p</i> < 0.05). Androgen receptor inhibition protects against cochlear injuries in KM-induced hearing loss rats by attenuating megalin expression, revealing anti-inflammatory and anti-apoptotic effects.
first_indexed 2024-03-10T11:17:57Z
format Article
id doaj.art-42cfb03d82964234876e07be1abdd4c5
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T11:17:57Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-42cfb03d82964234876e07be1abdd4c52023-11-21T20:16:22ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-05-012210530710.3390/ijms22105307Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in RatsKyung-Ju Chun0Chang-Ho Lee1Kyung-Woon Kim2So-Min Lee3So-Young Kim4Department of Otorhinolaryngology-Head & Neck Surgery, CHA University College of Medicine, Seongnam 13496, KoreaDepartment of Otorhinolaryngology-Head & Neck Surgery, CHA University College of Medicine, Seongnam 13496, KoreaDepartment of Otorhinolaryngology-Head & Neck Surgery, CHA University College of Medicine, Seongnam 13496, KoreaDepartment of Otorhinolaryngology-Head & Neck Surgery, CHA University College of Medicine, Seongnam 13496, KoreaDepartment of Otorhinolaryngology-Head & Neck Surgery, CHA University College of Medicine, Seongnam 13496, KoreaMegalin has been proposed as an endocytic receptor for aminoglycosides as well as estrogen and androgen. We aimed to investigate the otoprotective effects of antiandrogens (flutamide, FM) on kanamycin (KM)-induced hearing loss in rats. Rats were divided into four groups. The KM group was administered KM (20 mg/kg/day) for 5 days, while the FM group received FM (15 mg/kg/day) for 10 days. In the KM + FM group, KM and FM (15 mg/kg/day) were simultaneously injected for 5 days and then FM was injected for 5 days. Auditory brainstem responses were measured. Western blotting and/or quantitative reverse transcriptase-polymerase chain reaction were performed for megalin, cytochrome P450 1A1 (Cyp1a1), Cyp1b1, metallothionein 1A (MT1A), MT2A, tumor necrosis factor (TNF)-α, caspase 3, and cleaved caspase 3. The FM + KM group showed attenuated auditory thresholds when compared with the KM group at 4, 8, 16, and 32 kHz (all <i>p</i> < 0.05). The KM + FM group showed lower megalin and Cyp1b1 levels than the KM group (all <i>p</i> < 0.05). The KM + FM group revealed lower MT1A, TNFα, and caspase 3 protein levels, compared with those in the KM group (all <i>p</i> < 0.05). Androgen receptor inhibition protects against cochlear injuries in KM-induced hearing loss rats by attenuating megalin expression, revealing anti-inflammatory and anti-apoptotic effects.https://www.mdpi.com/1422-0067/22/10/5307receptors, androgenaminoglycosideshearing losslow-density lipoprotein receptor-related protein-2metallothionein
spellingShingle Kyung-Ju Chun
Chang-Ho Lee
Kyung-Woon Kim
So-Min Lee
So-Young Kim
Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
International Journal of Molecular Sciences
receptors, androgen
aminoglycosides
hearing loss
low-density lipoprotein receptor-related protein-2
metallothionein
title Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
title_full Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
title_fullStr Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
title_full_unstemmed Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
title_short Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats
title_sort effects of androgen receptor inhibition on kanamycin induced hearing loss in rats
topic receptors, androgen
aminoglycosides
hearing loss
low-density lipoprotein receptor-related protein-2
metallothionein
url https://www.mdpi.com/1422-0067/22/10/5307
work_keys_str_mv AT kyungjuchun effectsofandrogenreceptorinhibitiononkanamycininducedhearinglossinrats
AT changholee effectsofandrogenreceptorinhibitiononkanamycininducedhearinglossinrats
AT kyungwoonkim effectsofandrogenreceptorinhibitiononkanamycininducedhearinglossinrats
AT sominlee effectsofandrogenreceptorinhibitiononkanamycininducedhearinglossinrats
AT soyoungkim effectsofandrogenreceptorinhibitiononkanamycininducedhearinglossinrats